Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03224221
What this trial is testing

Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Anhui Medical University 189
Testing effectiveness (Phase 2)UnknownNCT04548271
What this trial is testing

Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 25
Not applicableUnknownNCT03722875
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 45
Large-scale testing (Phase 3)UnknownNCT05049681
What this trial is testing

Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell

Who this might be right for
Esophageal Cancer
Feng Wang 234
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06764368
What this trial is testing

Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Beijing Chest Hospital 39
Testing effectiveness (Phase 2)UnknownNCT04723030
What this trial is testing

The Transformation of Locally Advanced Pancreatic Cancer.

Who this might be right for
Locally Advanced Pancreatic Cancer
Peking University 30
Not applicableLooking for participantsNCT06485271
What this trial is testing

A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer

Who this might be right for
Gastric CancerRWSPD-1 Immunotherapy
Changzhi People's Hospital Affiliated to Changzhi Medical College 504
Testing effectiveness (Phase 2)Study completedNCT04642664
What this trial is testing

Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinomaBiomarker+1 more
Peking Union Medical College Hospital 22
Testing effectiveness (Phase 2)Study completedNCT04869488
What this trial is testing

A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 93
Post-approval studies (Phase 4)UnknownNCT05029453
What this trial is testing

Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy

Who this might be right for
Gastric CancerRandomized Controlled Study
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Testing effectiveness (Phase 2)Looking for participantsNCT06607770
What this trial is testing

Safety and Efficacy of Cryoablation With Karelizumab and Apatinib for Multiple Lung Cancers

Who this might be right for
Lung Cancer
Zhou Chengzhi 20
Large-scale testing (Phase 3)UnknownNCT02702323
What this trial is testing

Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study

Who this might be right for
Hepatocellular CarcinomaPulmonary Metastasis
Zhejiang Cancer Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236528
What this trial is testing

Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma

Who this might be right for
Mucosal Melanoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 30
Testing effectiveness (Phase 2)Study completedNCT03394287
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC

Who this might be right for
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40
Early research (Phase 1)Looking for participantsNCT06181032
What this trial is testing

Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies

Who this might be right for
Biliary Tract Malignancies
First Affiliated Hospital of Fujian Medical University 35
Testing effectiveness (Phase 2)UnknownNCT04715633
What this trial is testing

PD-1 Inhibitors Combined With VEGF Inhibitors for Locally Advanced dMMR/MSI-H Colorectal Cancer

Who this might be right for
Colorectal CancerMicrosatellite Instability High
Sun Yat-sen University 53
Testing effectiveness (Phase 2)Study completedNCT05223088
What this trial is testing

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Who this might be right for
ImmunotherapyGastrict Cancer
Fujian Cancer Hospital 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04208347
What this trial is testing

Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer

Who this might be right for
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital 580
Early research (Phase 1)Study completedNCT03075462
What this trial is testing

Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients

Who this might be right for
Ovarian CancerTriple Negative Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 98
Testing effectiveness (Phase 2)UnknownNCT04479527
What this trial is testing

Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Peking University Cancer Hospital & Institute 34
Next Page